Molecular Inflammation Board at the Center for Personalized Medicine — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Molecular Inflammation Board at the Center for Personalized Medicine — Stella

Recruiting

Back to Psoriasis (PsO) trials

Trial locations(1 site)

Germany

University Hospital of Tübingen - Center for Personalized Medicine, Tübingen

Key details

Sponsor

University Hospital Tuebingen

Collaborators

University Hospital Freiburg, University Hospital Heidelberg

Enrollment target

~3,000 participants

Started

November 2022

Primary completion

November 2032

Age range

18 Years and older

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov